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1. Introduction
The past fifteen years has seen a rapid rise in probiotic 
products being sold worldwide. There are several reasons 
for this, including companies with multinational sales reach, 
evidence generated from clinical studies that supports 
the consumers’ need for products with health benefits, 
and a recognition that microbes play an enormous role in 
human and planetary life (Horton and Lo, 2015; Omenn, 
2010; Postler and Gosh, 2017; Younes et al., 2017). Many 
studies have documented the positive effects of probiotics 
and fermented foods (Hill et al., 2014; Marco et al., 2017), 
further increasing the demand for the products.
However, there is deficit in the inability of products to 
reach arguably the neediest women, men and children in 
developing countries. It is in sub-Saharan Africa, including 
Kenya, Tanzania and Uganda, in Asian countries like Nepal 
and Bangladesh, and in parts of South America where 
poverty and malnutrition take a massive toll in terms of 
morbidity and average lifespan (World Atlas, 2017; World 
Statistics, 2014).
Expanding the reach of probiotics through social enterprises
G. Reid1*, R. Kort2,3,4, S. Alvarez5, R. Bourdet-Sicard6, V. Benoit7, M. Cunningham8, D.M. Saulnier9, J.E.T. van 
Hylckama Vlieg10, H. Verstraelen11 and W. Sybesma2
1Canadian Research and Development Centre for Probiotics, Microbiology & Immunology, and Surgery, University of Western 
Ontario, Room F3-106, P.O. Box 5777, STN B , London, N6A 4V2 Ontario, Canada; 2Yoba for Life foundation, Hunzestraat 133-
A, 1079 WB Amsterdam, the Netherlands; 3TNO Microbiology and Systems Biology, P.O. Box 360, 3700 AJ Zeist, the Netherlands; 
4VU University Amsterdam; Micropia, Natura Artis Magistra, Plantage Kerklaan 38-40, 1018 CZ Amsterdam, the 
Netherlands; 5Reference Centre for Lactobacilli (CERELA-CONICET), Chacabuco 145, Tucuman 4000, Argentina; 
6Danone Access, Africa & India, Danone Nutricia Research, Avenue de la Vauve, 91767 Palaiseau, France; 7General Mills, 
Nutrition and Technology Solutions, 9000 Plymouth Avenue N, Minneapolis, MN 55427, USA; 8Research and Development, 
Metagenics (Aust) Pty Ltd., P.O. Box 675, Virginia BC, Queensland 4014, Australia; 9Novozymes A/S, Hillerødgade 42, 2200 
Frederiksberg, Denmark; 10Chr Hansen AS, Bøge Alle 10, 2970 Hoersholm, Denmark; 11Vulvovaginal Disease Clinic, Dept. 
of Obstetrics & Gynaecology, Ghent University Hospital 0P4, Corneel Heymanslaan 10, 9000 Gent, Belgium; gregor@uwo.ca
Received: 28 January 2018 / Accepted: 20 March 2018 
© 2018 Wageningen Academic Publishers
OPINION PAPER
Abstract
The rapid rise in microbiome and probiotic science has led to estimates of product creation and sales exceeding 
$50 billion within five years. However, many people do not have access to affordable products, and regulatory 
agencies have stifled progress. The objective of a discussion group at the 2017 meeting of the International Scientific 
Association for Probiotics and Prebiotics was to identify mechanisms to confer the benefits of probiotics to a larger 
portion of the world’s population. Three initiatives, built around fermented food, were discussed with different 
methods of targeting populations that face enormous challenges of malnutrition, infectious disease, poverty and 
violent conflict. As new candidate probiotic strains emerge, and the market diversifies towards more personalised 
interventions, manufacturing processes will need to evolve. Information dissemination through scientific channels 
and social media is projected to provide consumers and healthcare providers with rapid access to clinical results, 
and to identify the nearest location of sites making new and affordable probiotic food and supplements. This rapid 
translation of science to individual well-being will not only expand the beneficiaries of probiotics, but also fuel new 
social enterprises and economic business models.
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The reported observations of Metchnikoff equating 
longevity with intake of fermented milk (Podolsky, 1998) 
have been part of the philosophy behind probiotics – 
replenishment of beneficial microbes. Prospective and 
retrospective studies correlate intake of fermented food with 
lower rates of bladder cancer, cardiovascular disease and 
type II diabetes (Keszei et al., 2010; Sonestedt et al., 2011), 
non-communicable diseases that affect more and more 
people living in the developing world (Allen et al., 2017).
A stumbling block in making probiotics available to the 
poorest people on the planet, in terms of financial and 
dietary poverty, is the strategic choice of most probiotic 
companies to work with business models that do not target 
people living at the bottom of the pyramid. Probiotic 
products are sold in some developing countries as premium 
products, which, for the people who might need them 
most, are simply unaffordable. Deficient infrastructure 
and access to good quality milk are often issues that would 
require a high investment. Sending finished products under 
humanitarian aid, is difficult due to the need to refrigerate 
finished foods like yogurt, and could at best only bring 
temporary relief.
Africa has a rich and long history of people making 
traditional fermented foods. Further development of 
these as delivery vehicles for probiotic bacteria could 
contribute towards reaching the United Nations Millennium 
Development Goals of eradication of poverty and hunger, 
reduction in child mortality rates and improvement of 
maternal health (Franz et al. 2014; United Nations, 2015). 
A forum was set up at the 2017 annual meeting of the 
International Scientific Association for Probiotics and 
Prebiotics (ISAPP) to discuss and understand the success 
of initiatives that provide people in the most challenging 
environments with access to probiotic food.
2. The Argentinian example
The process by which Lactobacillus rhamnosus CRL1505 has 
become integrated into the Official Nutritional Programs of 
Argentina and given to more than three hundred thousand 
children during school days provides an inspiring lesson 
for all countries. This probiotic strain was isolated from 
goat milk in north-western Argentina by scientists at the 
CERELA-CONICET research institute in Tucuman and 
shown through a series of studies to reduce the incidence 
and severity of intestinal and respiratory infections in 
children (diarrhoea, upper airway infections, pharyngitis 
and tonsillitis) and significantly increase immunoglobulin 
A in saliva (Salva et al., 2010). The strain influenced lung 
immune-coagulative reaction triggered by Toll-like receptor 
3 activation and its ability to modulate the production of 
pro-inflammatory and anti-inflammatory mediators helped 
it clear respiratory syncytial virus and influenza virus, and 
still control immune-coagulative responses and normal 
function in the lung despite viral attack (Zelaya et al., 2014).
A yogurt containing the CRL1505 strain was produced 
and tested on children attending preschool day-care 
community centres using a randomised, double blind, 
placebo controlled study. The significant decrease in the 
duration and severity of respiratory disease (Villena et 
al., 2012) attracted the attention of people working at the 
provincial government. They decided to cover the cost of 
making it available to all children in financially challenged 
school districts. In time, the national government decided 
to expand the reach around the country using different 
manufacturers. The term ‘Probiotics for Everyone’ was 
adopted as the slogan for the program (Villena et al., 2012).
Recognising the different taste and texture preferences of 
the population, the probiotic is now produced as Yogurito 
in yogurt, as well as different formulations, including a 
chocolate drink. For a country that is not ranked highly for 
its gross domestic product (GDP) (Countryeconomy.com, 
2017), this clearly shows that it has prioritised nutrition 
in children.
Although the financial support by the Argentinan local 
governments can be seen as an example for many other 
countries, government priorities may change and the 
program could be cancelled. In that case, other means of 
program support need to be found or the recipients will 
return to being depleted of the benefits of the food. The 
Argentinian government hopes to generate a payback for the 
nation when children are healthier and attend classes more 
frequently, thereby improving the chances of a better future.
3. East Africa
A different model has been introduced to sub-Saharan 
countries and Nepal. The concept originated in 2004 in 
response to a call for assistance for people dying from 
HIV/AIDS. The loss of bread-winners and side effects of 
diarrhoea, skin rashes and fatigue from the disease and its 
treatment were placing enormous burden on women in 
the communities. A program termed Western Heads East 
(WHE) was established by the staff, faculty and students 
of The University of Western Ontario in London, Canada. 
Students went to Mwanza, Tanzania and taught a local 
women’s group how to produce yogurt supplemented with 
probiotic L. rhamnosus GR-1 (termed Fiti) (Reid, 2010). A 
series of studies showed that a number of health benefits 
could be accrued, including reduction in fatigue, diarrhoea 
and skin rashes, and in some cases improvement in CD4 
counts in HIV patients (Anukam et al., 2008; Irvine et 
al., 2010; Kort and Sybesma, 2012). Within a few years, 
eleven community kitchens were in operation in Mwanza 
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However, the GR-1 strain had to be propagated at a suitable 
site, in this case the National Institute for Medical Research, 
and the ‘yogurt mamas’ had to travel to collect it, and then 
complete the production of the yogurt. This was effective 
initially, but became too much work with increasing 
volumes. Eventually, the institute stopped producing the 
probiotic. Fortunately, a Dutch non-profit organisation, the 
Yoba for Life Foundation (Y4L), had discovered a way to 
avoid this propagation step. Started in 2011, Y4L created 
the L. rhamnosus Yoba 2012 strain, a clone of the world´s 
most documented probiotic bacterium L. rhamnosus GG. 
They deposited the strain at the BCCM/LMG bacterial 
culture collection (LMG 27229) after the original patent 
of L. rhamnosus GG expired. Sequence comparison 
could confirm that all technical and functional properties 
attributed to the original strain exist with the same level of 
certainty in the Yoba 2012 strain as in actual commercial 
clones of L. rhamnosus GG, branded as LGG® (Kort and 
Sybesma, 2012). They then created a two-strain sachet 
containing Yoba 2012 plus a Streptococcus thermophilus 
C106 strain that was highly efficient at fermenting milk 
(Kort et al., 2015; Westerik et al., 2016). They showed 
that a 1 gram sachet could produce 100 litres of probiotic 
fermented milk, including the propagated L. rhamnosus 
Yoba strain. They placed a simple diagram on the back of 
the label to describe the production steps.
This innovative breakthrough led to the establishment 
of community kitchens around Kampala in Uganda. The 
sachets are affordable for the yoghurt producers at around 
US$0.60 each, and once volumes of finished product reach 
20 litres, the production units (PUs) are profitable. In 2015, 
supported by a grant from the Canadian International 
Food Security Research Fund, researchers from WHE 
and Y4L teamed up with Heifer International and Jomo 
Kenyatta University of Agriculture and Technology to create 
a Fermented Food For Life (FFFL) program and leverage 
the probiotic starter culture innovation in order to reach 
250,000 consumers in Kenya, Tanzania and Uganda. With 
two months remaining of the funding over 220 PUs have 
been established in communities numbering in the millions 
of potential consumers where probiotics have never been 
made accessible. The locally operating PUs can be a single-
run business making 20 litres of yoghurt per batch, to larger 
enterprises making 1,500 litres per day with over twenty 
employees.
Many of the producers are traditional dairy farmers and 
others have previously sold regular yogurt. But, the sachet 
concept has allowed them to generate better returns for 
their social businesses. To facilitate easy access to the starter 
cultures, fifteen regional sachets distribution centres have 
been established in the three countries.
The process of establishing effective PUs begins by 
identifying people within communities who have access 
to milk and have affinity with food processing. Individuals 
or groups are trained in all the elements of the yogurt 
value chain, including milk quality control, hygienic 
production, packaging, marketing and book keeping. A key 
characteristic of the program is that all local producers sell 
under their own brand, and as a consequence they feel, and 
are responsible for, the quality of their own products. Some 
issues have arisen, where farmers have diluted milk before 
selling it to PUs; but this is why the lactometer is used. Milk 
curdling can occur and is usually a sign that the procedure 
has not been followed properly. Some smaller PUs have tried 
to use fractions of the sachets, in their eyes to save money, 
but the product quality has been poor in taste and texture. 
Rarely, when spoilage occurs, it is obvious to sight and taste, 
and these batches are destroyed. There has never been a 
case where the reason for problems with the fermented 
product has not been identified and corrected, which is 
testament to the process and diligence of the producers 
and trainers. One of the most urgent points for setting up 
a sustainable business with perishable food raw materials is 
the assurance of hygiene and good manufacturing practices. 
Hereto, the Yoba for Life foundation collaborates closely 
with the Dairy Development Authority with the aim to 
make sure that all local producers can comply with hygiene 
standards for food production.
All training materials are accessible free of charge (Yoba-
for-Life, 2017). In order to differentiate the probiotic yogurt 
from regular yogurts, the packaging carries a Yoba inside 
stamp to indicate the source of the cultures are the sachets 
(Figure 1). This is done to add value to the products since 
competitors will not be using such a well-documented 
probiotic, if they use any at all. Figure 2 illustrates active 
brand names of locally produced probiotic yogurts carrying 
the Yoba Inside label in Uganda. The weekly production 
volumes vary between 10 and 1,500 litres per day.
This program is an excellent example of translational 
microbiology that is designed to improve health and create 
wealth in form of economic activities and employment. The 
products improve health through delivery of a fermented 
food containing an effective probiotic strain. The acidified 
food inhibits pathogens that are in abundance in the local 
food and water (Drago et al., 1997; Kotloff et al., 2013) 
and the probiotic delivers prophylactic benefits through 
the production of by-products, such as short chain fatty 
acids, immune modulators and potentially neurochemicals 
(Kim et al., 2016; LeBlanc et al., 2017; Lyte, 2011; Rutten 
et al., 2011). An additional benefit of fermentation with 
a probiotic, is that all extracellular produced metabolites 
remain in the product, which is not the case when probiotics 
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4. Learnings from Bangladesh
The third model that was discussed focused on the growing 
population in Africa that is above the poverty line but 
is not affluent. Danone Communities is a mutual fund 
created ten years ago, with company employees contributing 
to fight malnutrition by empowering innovative social 
entrepreneurs to achieve sustainable social impact (Danone 
Communities, 2016; Yasmin, 2016). Danone Communities 
invests in social businesses as minority shareholders, 
providing capital in addition to technical and managerial 
expertise, with a view to eventually making a return on 
the investment.
The program started in Bangladesh in 2007, to alleviate 
malnutrition and develop a new business model generating 
income for local communities. A fermented dairy product, 
without a probiotic, was fortified with iron, iodine, vitamin 
A and zinc to cover 30% of a child’s daily requirement was 
developed and sold at a price affordable to poor people, 
by the newly created Grameen Danone Foods Ltd. The 
milk is collected from small, independent local farmers, 
thereby contributing to their income. The distribution 
model of the fortified product was by door-to-door in 
rural areas, using women micro-entrepreneurs, as well as 
via small retail shops, enabling social impact throughout 
the value chain. However, expansion to cities, including 
Dhaka, was necessary to accomplish social and financial 
sustainability of the production factory, according to one 
analysis which viewed the initiative as a charity rather than 
a social business (Yasmin, 2016). This author noted that 
target consumers lacked knowledge about the product’s 
benefits, and insufficient time was spent understanding 
their purchasing power, taste and preferences.
Nevertheless, the company claims to have reached three 
hundred thousand children in Bangladesh with the fortified 
yogurt providing a health benefit, as demonstrated by 
improved haemoglobin levels and linear growth (Sazawal 
et al., 2013).
Figure 1. Example packaging labels of local probiotic yoghurt producer in Uganda carrying the Yoba inside stamp as brand added 
benefit. This represents the breakthrough production of the sachet by Yoba-for-Life.
Figure 2. A word cloud listing the names of production units 
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In northern Senegal, Danone Communities supports a 
network that collects fresh milk twice a day from 600 Fulani 
herders (Danone Communities, 2016). The fermentation 
process does not contain a probiotic but does prevent 
milk spoilage. The social enterprise distributes a range 
of affordable yogurts and Thiakry (sweet millet couscous 
dish, inspired from local eating habits). The next challenge 
will be to fortify the products with vitamins and minerals 
while keeping them affordable. In addition to Senegal, 
this model is being replicated in Kenya, Madagascar, 
India, China and Cambodia, with the intent of reaching 
one million beneficiaries. In Kenya, Danone invested 
in Brookside Dairies with a view to providing a further 
means to target middle-income consumers. Although not 
supplementing their products with probiotic strains, 400 
local milk producers are enabling an estimated 70,000 
malnourished children to receive yogurt enriched with 
essential micronutrients. In short, this third example is 
led by a multinational company and targeting the low-
middle class.
5. Future directions
The three initiatives described all started by creating a 
strong basis at the supply side. In order to allow further 
expansion, stimulation of the demand side will be key. 
Information dissemination through scientific channels 
and social media is projected to provide consumers and 
healthcare providers with rapid access to clinical results, 
and identify the nearest location of sites making new and 
affordable probiotic food and supplements. This rapid 
translation of science to individual well-being will not only 
expand the beneficiaries of probiotics, but also fuel new 
social enterprises and economic business models. With 
widespread use of cell phones amongst all social classes, 
a texting app is currently being tested in rural Uganda to 
find out more about consumer responses to probiotics, 
and gauge whether availability of these fermented foods 
changes eating patterns. This methodology developed 
by the Dutch company ‘Text to Change’ has been proven 
useful in a number of studies to collect data from the field, 
on the demand as well the production site (De Lepper et 
al., 2013; Mangone et al., 2016).
The Argentinian model shows that economically poor 
countries can support distribution of these health-
promoting foods. Yet, even there fermented foods are not in 
the national Food Guide, nor are they in any other country 
surprisingly since their consumption could perhaps reduce 
the risk of lifestyle diseases (Chilton et al., 2015; Sybesma 
et al., 2017).
The three initiatives discussed herein all focus on milk. 
Although milk production is expected to increase 
substantially on the African continent (World milk 
production growth, 2015), which augers well for this 
program, it is not the most sustainable protein source in 
the daily diet, and during the dry season in Africa, milk 
production decreases. For this reason, and to expand the 
reach of the sachets to milk-poor countries, experiments 
were performed to show that the strains in the Yoba/Fiti 
sachets can also ferment millet, soy and corn (Di Stefano 
et al., 2017). Pearl millet, in particular, has a long history 
of use in Africa, and its drought resistance makes it a good 
crop to deliver the benefits of the probiotics. Its production 
decreased with the introduction of maize, which does not 
require the hulling and processing needed for millet. In 
addition, the yield from the nutrient-rich millet is not 
as high as other cereals (barely 600 kg per hectare) like 
maize, and it has been described as a ‘lost’ crop (Lost 
Crops, 1996). However, the sometimes-deadly aflatoxins 
released by Aspergillus sp. on contaminated maize (Kouadio 
et al., 2014), and the continued exposure of children to 
these toxins (Nduti et al., 2016) has led to proposals to 
return to consumption of fermented millet, in which the 
probiotic Yoba 2012 and GR-1 strains degrade the aflatoxins 
(Ahlberg et al., 2015; Mokoena et al., 2006; Musika et al. 
unpublished; Nduti et al., 2017; Verheecke et al., 2016). 
For maize and other cereals, the use of microorganisms to 
detoxify aflatoxins has been researched, and by means of 
the locally made probiotic fermented food, this is expected 
to contribute to the reduction of a significant disease risk 
factor (Sybesma et al., 2015).
The opportunity exists to identify microbes that can deliver 
specific benefits to inhabitants of tropical regions. For 
example, Lindsay et al. (2015) conducted a study with 
microbiota of the stools of 1,300 children with moderate-
to-severe diarrhoea and 1,735 without diarrhoea in 
Kenya, and reported a correlation between presence 
of some Lactobacillus species and protective additive 
effects against diarrhoea when infected with Shigella. In 
a follow-up study, it appeared that the supernatant of an 
Lactobacillus salivarius isolated from the stool of a Kenyan 
child inhibited growth of Shigella boydii, Shigella sonnei, 
Shigella dysenteriae and enterotoxigenic Escherichia coli 
(ETEC) in vitro (Stine O.C., personal communication). 
Future research will focus on the potential to make 
fermented food with this strain, and to verify its curative 
and/or preventive effect against Shigella induced diarrhoea.
6. Concluding remarks
We evaluated three different models of sustainable concepts 
designed to use local production and sales of probiotic 
fermented foods. All models include scalable, sustainable, 
knowledge intensive, and locally grounded innovations. 
Two of the options create value and operate in line with the 
principles of creating fortune at the bottom of the pyramid 
(Prahalad and Hart, 2002). The third non-probiotic model 
aims to bring highly nutritious and affordable foods to 
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The FFFL program and Danone do not provide any funds 
per se to local communities and producers, and budgets 
are only allocated to pay staff who facilitate trainings and 
coordination. Although the Yogurito concept is completely 
sponsored by the Argentina government, we reason that 
the expected return on investment in serving 300,000 
children daily with probiotic yoghurt will be positive 
because of reduced illnesses, fewer visits to doctors and 
higher school attendance. In addition to the generation of 
income for local producers and improvement in health of 
the populations consuming the probiotic supplemented 
fermented foods, the FFFL program touches all parts of 
the value chain as shown in Figure 3. Further generation 
of evidence substantiating societal and health benefits, and 
engagement of communities and government agencies will 
certainly strengthen the programs.
The initiatives described in this article show that there is a 
role for researchers aligned with governments (Yogurito), 
the private sector (Danone Communities), and civil society 
(WHE/Y4L) in helping the most challenged people on our 
planet who are faced with poverty, malnutrition, infectious 
diseases and acts of violence. Each element has its own 
strengths and weaknesses, opportunities and threats, as 
summarised in Table 1. By emphasising sustainability 
through empowering people to use local resources to 
combat malnutrition and poverty, many of the United 
Nations’ seventeen Sustainable Development Goals (SDGs) 
to end poverty, protect the planet, and ensure prosperity 
for all can be met (United Nations, 2014). The simple 
guidelines for success are to make it easy, understood, 
desirable, rewarding, and a habit.
As a take home message, three different initiatives are 
described in this paper that show the application of 
probiotics to poor people in developing countries who 
currently would not otherwise have access to their health-
promoting benefits. In the case of the East Africa example, 
the initiative also provides empowerment to women 
and dairy farmers, and socio-economic benefits to the 
producers.
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Table 1. SWOT (Strength, Weakness, Opportunity, Threat) analysis of three bottom of pyramid initiatives to improve health and 
wealth by means of locally produced probiotic fermented food. 
Strength Tailoring local solutions:
Probiotics with proven health benefits (YA, Yoba/Fiti)
Clinical studies conducted on target population (YA, Yoba/Fiti)
Tasty products that are locally accepted (YA, Yoba/Fiti, DC)
Use of starter cultures that prevent spoilage (YA, Yoba/Fiti, DC)
Creating buying power:
Income generating activities for local communities from all or several elements of the fermented food value chain (YA, Yoba/Fiti, DC)
Emphasising empowerment of youth and women (Yoba/Fiti, DC)
Affordable products with a popular price point enabled by low production costs, a limited amount of intermediaries and low margins 
(YA, Yoba/Fiti, DC)
Creating access:
Distribution of stable and dried seed cultures (Yoba/Fiti)
Local production (YA, Yoba/Fiti, DC)
Program supported by external sources (YA)
Products that are to a certain extent do not depend on the presence of a cold distribution chain (YA, Yoba/Fiti, DC)
Targeting areas with a lot of people, such as cities (DC)
Shaping aspirations:
Supported by local governments (YA)
Use of full length feature film to inform the public about probiotics (http://tinyurl.com/y8dq5kvs (Yoba/Fiti)
Involvement of local radio and television (Yoba/Fiti)
Local producers producing under their own brand united by a brand added benefit mark (Yoba/Fiti)
Creating one aspirational brand (DC)
Products anchored into existing eating habits that taste good and have a perceived functional (health) benefits (YA, Yoba/Fiti, DC)
Weakness Lack of knowledge and understanding of probiotics:
In local communities (Yoba/Fiti, DC)
Opportunities Tailoring local solutions:
Apply the starter cultures for production on non-dairy fermented foods such as cereals (Yoba/Fiti)
Conduct more quantitative and qualitative health studies addressing local needs, e.g. aflatoxin detoxification (YA, Yoba/Fiti, DC)
Creating access:
Scale-up by training more communities (Yoba/Fiti, DC)
Scale-up by increasing the production by each unit (Yoba/Fiti)
Expand the regions where government sponsors the product (YA, Yoba/Fiti)
Shaping aspirations:
Stimulate demand side by involvement of mobile communication to consumers (YA, Yoba/Fiti, DC)
Connect to school feeding programs (YA, Yoba/Fiti, DC)
Engage with local, regional and national policy makers by referring to the outcomes in Argentina and expected Health Economics and 
childhood learning (Yoba/Fiti, DC)
Make probiotic fermented food concepts as franchise formula for small production facilities in big cities (Yoba/Fiti)
Threat Lack of effective legislation and law enforcement risks imitation and counterfeiting with non-probiotic concepts (Yoba/Fiti, DC)
Lack of capacity to coordinate all elements required for expansion, including engagement with policy makers (Yoba/Fiti, DC)
Bureaucrats deciding to no longer provide funds for programs (YA)
1 The headers used in this SWOT analysis originate from the principles of creating fortune at the bottom-of-pyramid.
2 YA = Yogurito Argentina; Yoba/Fiti is a program using sachets containing Streptococcus thermophilus plus either Lactobacillus rhamnosus Yoba or 
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is a scientist with no personal affiliation with any of the 
probiotics discussed.
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